Apparent mineralocorticoid excess: Type I and type II

Steroids

Volumn 61, Issue 4, 1996, Pages 193-196

  Mantero, Franco ^a,e   Palermo, Mario ^b   Petrelli, Massimiliano D ^a   Tedde, Rinaldo ^b   Stewart, Paul M ^c   Shackleton, Cedric H L ^d  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^e Ospedale Regionale Torrette   (Italy)

Author keywords

11 hydroxysteroid dehydrogenase; apparent mineralocorticoid excess types I and II; cortisol metabolism

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR;

CLINICAL FEATURE; CONFERENCE PAPER; CORTICOSTEROID METABOLISM; DISEASE CLASSIFICATION; ENZYME DEFICIENCY; GENE MUTATION; HYPERCORTISOLISM; HYPERTENSION; HYPOKALEMIA; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY;

GLYCYRRHIZA; IRANIA;

EID: 0030002945     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(96)00012-8     Document Type: Conference Paper

References (34)

1. New MI, Levine LS, Biglieri EG, Pariera J, Ulick S (1977). Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 44:924.
2. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosler A, Bradlow HL, New MI (1979). A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 49:757.
3. Werder E, Zachman M, Vollmin JA, Veyrat R, Prader A (1974). Unusual steroid excretion in a child with low renin hypertension. Res Steroids 6:385.
4. Shackleton CHL, Honour JW, Dillon MJ, Chantier C, Jones RW (1980). Hypertension in a four-year-old child; gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids. J Clin Endocrinol Metab 50:786.
5. Fiselier TJW, Otten BJ, Monnens LAH, Honour JW, Van Munster PJJ (1982). Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month old child. Horm Res 16:107.
6. Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CRW (1990). Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin Sci 78:49.
7. Oberfield SE, Levine LS, Carey RM, Greig F, Ulick S, New MI (1983). Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 56:332.
8. Edwards CRW, Stewart PM, Nairn IM, Grieve J, Shackleton CHL (1985). Cushing's disease of the kidney. J Endocr 104:53 (Abstr.)
9. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW (1988). Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 82:340.
10. Tedde R, Pala A, Melis A, Ulick S (1992). Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess. J Endocr Invest 15:471.
11. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987). Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268.
12. Harinck HIJ, van Brummelen P, van Seters AP, Moolenaar AJ (1984). Apparent mineralocorticoid excess and deficient 11β-oxidation of cortisol in a young female. Clin Endocrinol 21:505.
13. Dimartino-Nardi J, Stoner E, Martin K, Balfe JM, Jose PA, New MI (1987). New findings in apparent mineralocorticoid excess. Clin Endocrinol 27:49.
14. Sann L, Revol A, Zachmann M, Legrand JC, Bethenod M (1975). Unusual low plasma renin hypertension in a child. J Clin Endocrinol Metab 43:265.
15. Honour JW, Dillon MJ, Levin M, Shah V (1983). Fatal low renin hypertension associated with a disturbance of cortisol metabolism. Arch Dis Child 58:1018.
16. Shackleton CHL, Rodriguez J, Arteaga E, Lopez JM, Winter JSD (1985). Congenital 11β-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. Clin Endocrinol 22:701.
17. Milford DV, Shackleton CHL, Stewart PM (1995). Mineralocorticoid hypertension and congenital deficiency of 11β-hydroxysteroid dehydrogenase in a family with the syndrome of apparent mineralocorticoid excess. Clin Endocrinol 42: in press.
18. New MI (1994). The prismatic case of apparent mineralocorticoid excess. J Clin Endocrinol Metab 79:1.
19. Ulick S, Tedde R, Wang JZ (1992). Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 74:593.
20. Mantero F, Tedde R, Opocher G, Dessi Fulgheri P, Arnaldi G, Ulick S (1994). Apparent mineralocorticoid excess type II. Steroids 59:80.
21. Ulick S, Tedde R, Mantero F (1990). Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 70:200.
22. Epstein MT, Espiner EA, Donald RA, Hughes H (1977). Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. Br Med J 1:488.
23. Turpie AGG, Thomson TJ (1965). Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects. Gut 5:591.
24. Reevers F (1946). Behandling van uleus ventriculi in uleus duodeni met succus liquriate. Ned Tijdschr Geneesk 92:2968.
25. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CHL, Edwards CRW (1987). Mineralocorticoid activity of liquorice: 11beta hydroxysteroid dehydrogenase deficiency comes of age. Lancet ii:821.
26. MacKenzie MA, Hofnagels WHL, Jansen RWMM, Benraad TJ, Kloppenborg PWC (1990). The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers. J Clin Endocrinol Metab 70:1637.
27. Souness GW, Morris D (1991). The mineralocorticoid-like actions conferred on cortisone by carbenoxolone are inhibited by the mineralocorticoid receptor (type 1) antagonist RU28318. Endocrinology 129:2451.
28. Lakshmi V, Monder C (1988). Purification and characterization of the corticosteroid 11beta dehydrogenase component of the rat liver 11beta hydroxysteroid dehydrogenase complex. Endocrinology 123: 2390.
29. Whorwood CB, Franklyn JA, Sheppard MC, Stewart PM (1992). Tissue localization of 11beta-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. J Steroid Biochem Mol Biol 41:21.
30. Stewart PM, Whorwood CB, Barber P, Gregory J, Monder C, Franklyn JA, Sheppard MC (1991). Localization of renal 11beta-dehydrogenase by in situ hybridization: autocrine not paracrine protector of the mineralocorticoid receptor. Endocrinology 128:2129.
31. Mercer WR, Krozowski ZS (1992). Localization of an 11beta-hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology 130:540.
32. Walker BR, Campbell JC, Williams BC, Edwards CRW (1992). Tissue-specific distribution of the NAD+ dependent isoform of 11beta hydroxysteroid dehydrogenase. Endocrinology 131:970.
33. Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MT, Wei JQ, Shackleton CHL, Funder JW, New MI (1995). A mutation in the HSD1 1B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263.
34. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC (1995). Human hypertension caused by mutation in the kidney isozyme of 11beta-hydroxysteroid dehydrogenase. Nat Genet 10:394.